JNJJOHNSON & JOHNSONSEC EDGAR
Use with Claude or ChatGPT

JOHNSON & JOHNSON (JNJ) Overview

Healthcare • NYSE • CIK 0000200406

Loading...

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Market Cap
$682.62B
P/E (TTM)
42.4x
Rev Growth (TTM)
+7.8%
Net Margin (TTM)
16.2%
FCF Yield (TTM)
3.0%
FCF Margin (TTM)
20.7%
Figures as of September 27, 2026
Data coverage notes

Operating income: no tagged operating-income figure (OperatingIncomeLoss) resolved for the trailing twelve months, so MetricDuck computes revenue minus total costs and expenses as it totals them; it is not a figure the filing tags as operating income. Operating margin, interest coverage, ROIC and EV/EBIT are built on it; no EBIT is synthesised.

Filings

Primary-source SEC disclosures, read end-to-end. SEC figures cite the filing they come from.

10-Q2026 Q32026-10-21source
8-KEarnings2026-10-13source
8-KAug 20262026-08-04source
8-KJul 20262026-07-29source
8-KJul 20262026-07-28source
What your agent reads

Investor Relations

www.investor.jnj.com/financials/quarterly-results/default.aspx

Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.

Company-published, not SEC-audited

Earnings

Q3
about 1 month ago
8-K release
Revenue
$25.40B
+5.9%
Net Income
$210.00M
-95.9%
EPS
N/A
—
Earnings call2026 Q2· issuer-publishedtranscript
Most recent quarterly earnings snapshot

Cash Flow Health

Free Cash Flow8/8 positive
TTM$20.6B
Q3 '26
$6.4B-13%
Q2 '26
$7.3B+398%
FCF Margin
TTM20.7%
Q3 '2625.0%-13%
Sector: 3.3%Top 25%
OCF Margin
26.3%
OCF/NI1.63x
CapEx Coverage
4.7x
FCF Yield3.0%
FCF Growth (3Y)+9%
Cash Conversion Cycle
116 days
DSO: 66+DIO: 166−DPO: 117
Factsheet →
Cash flow trends & capital efficiency

Capital Allocation

Total Shareholder YieldTTM
TTM3.0%
Div Yield1.9%
+
Buyback (TTM)1.2%
Dividend & Payout Metrics
Dividend Yield (TTM)1.9%
FCF Payout Ratio61.7%
Free Cash Flow (TTM)$20.6B
Stock Repurchases (TTM)$7.9B
Capital Return / FCF100.0%
Shares Outstanding (YoY)-0.1%↓ Buyback
Est. Dividends Paid (TTM)$12.7B
Shows how management rewards shareholders

Valuation Metrics

Price-to-EarningsTTM
42.4x
Volatile
8Q: 24.9x+44939%
High PEG ratio (5.4x) suggests expensive for growth
Valuation Lenses
Earnings
42.4x
vs – sector
Cash Flow
34.5x
EV/FCF vs –
Growth-Adj
5.4xPEG
Expensive for growth
Quality-Adj
2.4P/E per %ROIC
ROIC: 17.6%
Shareholder Returns
Dividend
1.9%
Buyback
1.2%
Total Yield
3.0%
Market Cap$682.62B
EV$710.04B

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Multi-angle valuation analysis with sector context

Margins & Efficiency

ROIC 75th pctile
Profitability Cascade
Gross
67.6%
Operating
25.7%
Top 25% in sector
Net
16.2%
Margins Unknown
Return on Invested CapitalTTM
17.6%
Stable
+0.0% YoY8Q: 17.1%+7.6%
P25MedianP75
75th pctl (med: -8.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
23.3%
8Q: 23.2%
Asset Turnover
0.50x
8Q: 0.50x
Leverage (1+D/E)
1.55x
D/E: 0.55x
DuPont: 18.0% ≈ 17.6% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
4.26x
8Q:4.32x
-11.4%
Invested Cap Turn
0.80x
8Q:0.80x
Flat
CapEx Intensity
4.5%
8Q:4.0%
CapEx/Depreciation
0.69x
FCF vs Net Margin Gap+4.5 pts
Margin trends, ROIC, and capital efficiency

Balance Sheet & Solvency

ND/EBITDA 0.9x
Net Debt / EBITDA
0.9xNet Debt: $27.42B
Interest Coverage
25.9x
+Strong interest coverage: 25.9x
Leverage Metrics
Debt-to-Equity
0.55x
Balance sheet risk & solvency analysis

Related Research

1 related post